Precision BioPharma is an innovative company with an Adaptive Translational Research approach and a rich pipeline of antivirals.
Our lead compound, PB-004, has a huge potential to save lives of COVID-19 patients through four or more mechanisms.
- It works as a stronger anti-viral against COVID-19 and is more potent than the leading anti-viral in use, as well as it posses Anti-Inflammatory, Immunomodulatory and Anti-Clotting mechanisms.
- PB-004 provide robust protection against COVID-19 infection and multi-organ system complications such as ARDS, cytokine storm, clotting and blood vessel damage.
- PB-004 is FDA approved and safe to use, so it can be repurposed easily using our adaptive Phase 2/3 trial with accelerated Pre-Clinical testing.